REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Immunoglobulin, Antiserum, Antibody, Or Antibody Fragment, Except Conjugate Or Complex Of The Same With Nonimmunoglobulin Material > Binds Virus Or Component Thereof Binds Virus Or Component ThereofBinds Virus Or Component Thereof patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/26/07 - 20070172489 - Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza The invention relates to the use of at least one caspase inhibitor, in particular a caspase-3 inhibitor, for preparing a pharmaceutical composition for the prophylaxis and/or therapy of a viral infection, in particular an infection with an RNA negative-strand virus, preferably an influenza infection, and to a test system for ... 06/28/07 - 20070148180 - Peptide-immunoglobulin-conjugate The current invention is related to peptide-immunoglobulin-conjugates in which at least two of the termini of the immunoglobulin polypeptide chains are conjugated to a peptide, whereby the peptides can be different, similar or identical. The conjugation is effected on the nucleic acid level. ... 06/14/07 - 20070134256 - Monoclonal antibodies that bind or neutralize dengue virus The present invention relates to monoclonal antibodies that bind or neutralize dengue type 1, 2, 3, and/or 4 virus. The invention provides such antibodies, fragments of such antibodies retaining dengue virus-binding ability, fully human or humanized antibodies retaining dengue virus-binding ability, and pharmaceutical compositions including such antibodies. The invention further ... 06/14/07 - 20070134255 - Hmpv treatment with ribavirin and anti-hmpv antibody The invention relates to antimicrobial agents and antibodies and compositions comprising such agents and antibodies to treat and/or prevent respiratory and related diseases, in particular those caused by human metapneumovirus. Provided is a method for treating or preventing respiratory tract infections in a subject infected with a mammalian MPV, said ... 05/17/07 - 20070110757 - Antibody formulations having optimized aggregation and fragmentation profiles The present invention provides methods of optimizing the production and purification of antibody formulations that immunospecifically bind to antigens of interest and are suitable for parenteral administration to a subject, which formulations exhibit increased stability due to reduced degradation and aggregation of the antibody component on long term storage. Such ... 04/26/07 - 20070092524 - Method for the treatment and prophylaxis of avian influenza infection This invention relates to methods and compositions for treatment and prevention of Avian Influenza. Specifically, the invention relates to the use of immunoglobulins obtained from a subject immune to Avian Influenza in the preparation and use of pharmaceutical preparations for the treatment of Avian Influenza. ... 04/26/07 - 20070092523 - Combination therapy of respiratory diseases using antibodies Therapeutically effective anti-microbial compositions, useful especially against respiratory diseases caused or mediated by viruses, bacteria, and other respiratory parasites are disclosed, wherein said compositions comprise at least one neutralizing antibody, including high affinity antibodies, and an additional anti-infectious agent, such as an antiviral agent, for example, ribavirin, amantadine, rimantadine, or ... 04/12/07 - 20070082002 - Neutralizing high affinity human monoclonal antibodies specific to rsv f-protein and methods for their manufacture and therapeutic use thereof A highly efficient method for generating human antibodies in particular which are specific to be RSV fusion protein which combines in vitro primary of human spleen cells and antigen boosting in SCID mice is taught. This method provides for very high human antibody titers which are predominantly of the IgG ... 03/22/07 - 20070065452 - Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases The invention provides methods and compositions for the treatment and prevention of a transmittable disease in a subject, such as avians and mammals. The methods and compositions of the invention specifically make use of avian antibodies to the disease to be treated or prevented. Administration of such avian antibodies to ... 03/08/07 - 20070053916 - Replikin peptides in rapid replication of glioma cells and in influenza epidemics Peptides of influenza virus hemagglutinin protein and Plasmodium falciparum malaria antigen, antibodies specific for the peptides, influenza vaccines, malaria vaccines and methods of stimulating the immune response of a subject to produce antibodies to influenza virus or malaria are disclosed. Also disclosed are methods for formulating vaccines for influenza virus. ... 02/22/07 - 20070041985 - Modulation of the poliovirus receptor function The present invention relates to the identification, the isolation and the use of molecules interfering with the function(s) mediated by the poliovirus receptor (PVR) on cells. The molecules can be used for the treatment of cells having a metastatic potential, metastasis and cancer. Further methods are provided that are useful ... 01/25/07 - 20070020279 - Human-murine chimeric antibodies against respiratory syncytial virus This invention relates to a human antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody, against respiratory syncytial virus which is MAb 1129 and the use thereof for the prevention and/or treatment of RSV infection. ... 01/11/07 - 20070009537 - Antimicrobial activity of antibodies producing reactive oxygen species The invention provides compositions having antibodies that can generate reactive oxygen species when exposed to singlet oxygen, as well as methods of using the compositions, for example, to treat microbial infections. ... 12/14/06 - 20060280750 - Toxin-related antibodies with antimicrobial and antiviral activity Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity. Fragments (e.g. decapeptides) of these anti-idiotypic antibodies, particularly those comprising CDR residues, also show microbicidal activity, as do peptides having 5 the same sequence but composed of D-amino acids, or including amino ... 11/16/06 - 20060257411 - Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway Compositions and methods are provided for screening and identifying compounds which modulate signaling of toll-like receptor 4 (TLR4) pathway via CD14 and a ligand. Methods are provided for treatment of various disease states such as inflammation or autoimmune disease in mammalian subjects by modulating toll-like receptor 4 (TLR4) pathway signaling ... 11/09/06 - 20060251663 - Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability The present invetnion refers to the use of rotavirus proteins VP4, VP8 and their derived fusion proteins and peptides, for enhancing the delivery of pharmaceutical agents through the paracellular pathway. These rotavirus proteins and derived peptides may additionally be employed to reduce unwanted cellular adhesion that can occur between cancerous ... 10/19/06 - 20060233812 - Focussed antibody technology The present invention concerns methods for identifying candidate sequences for antibody specific against an antigen produced by a micro-organism during an infection or against a vaccine, methods of manufacture of medicaments, and methods of treatment of patients using same. Also provided is a method for determining the efficacy of a ... 10/12/06 - 20060228367 - Antibodies against mammalian metapneumovirus The present invention provides antibodies that immunospecifically bind to a polypeptide of a mammalian metapneumovirus, compositions comprising said antibodies, and methods for producing such antibodies. In particular, the invention provides monoclonal antibodies that immunospecifically bind to the F protein of human metapneumovirus and that neutralize human metapneumovirus. The invention also ... 09/28/06 - 20060216300 - Recombinant antibodies and compositions and methods for making and using the same Methods and compositions are provided for the use of rabies virusneutralizing antibodies for postexposure prophylactic treatment of subjects exposed to rabies virus. Compositions comprising mixtures of rabies virusneutralizing antibodies, as well as nucleotide and amino acid sequences encoding these antibodies, can be used in the treatment of subjects exposed to ... 09/21/06 - 20060210574 - Pharmaceutical compositions and articles of manufacture useful in reversal of a clinical epiosode of an incurable disease and methods of use thereof A method of reversing a clinical episode of a disease which is generally considered incurable in a subject. The method includes providing an immune-globulin preparation containing a detectable titre of antibodies to the disease which is generally considered incurable and administering the immune-globulin preparation to the subject. Preferably, the immune ... 09/07/06 - 20060198848 - Methods and compositions for treating herpes infections A method of treatment or prophylaxis of herpes infections and associated disease states by administration of compositions comprising immunoglobulins. Methods comprising intravenous and topical administration of immunoglobulins are provided. ... 07/13/06 - 20060153855 - Prevention and treatment of the porcine reproductive and respiratory syndrome (prrs) The present invention relates to the use of compositions of specific anti-PRSSV immunoglobulins obtained from the egg yolk of hens hyperimmunized with PRRS virus. The immunoglobulins are obtained through the extraction of the aqueous phase of the yolk through the use of hydroxypropylmethylcellulose phtalate at a final concentration of 0.05% ... 06/01/06 - 20060115485 - Methods of preventing and treating rsv infections and related conditions The present invention provides methods for preventing, managing, treating and/or ameliorating a Respiratory Syncytial Virus (RSV) infection (e.g., acute RSV disease, or a RSV upper respiratory tract infection (URI) and/or lower respiratory tract infection (LRI)), otitis media (preferably, stemming from, caused by or associated with a RSV infection, such as ... 05/25/06 - 20060110399 - Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin The solvent-detergent (S/D) process is used to inactivate enveloped viruses in plasma products. While concentrations of 1.0% detergent and 0.3% tri-n-butyl phosphate solvent have been considered necessary for robust removal of viral activity, we show the effectiveness of solvent-detergent treatment after fractionation and nanofiltration of an immune gamma globulin preparation, ... 03/30/06 - 20060067940 - Antibodies against west nile virus and therapeutic and prophylactic uses thereof The present invention relates to compositions comprising antibodies or fragments thereof that immunospecifically bind to one or more antigens of a flavivirus, particularly of West Nile Virus (WNV), and methods for preventing, treating or ameliorating symptoms associated with a flavivirus, particularly of West Nile Virus (WNV), infection utilizing said compositions. ... 03/23/06 - 20060062794 - Composition containing particle surface charge control agent, particle separating method using same, particle separator The present invention is a composition for modifying an amount of charges on a surface of a target particle in a sample and separating or quantitatively determining the target particle in the sample, based on the modified surface charge amount, and relates to the composition comprising a charge control agent ... 03/16/06 - 20060057149 - Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof The present invention relates to compositions comprising humanized antibodies or fragments thereof that immunospecifically bind to one or more antigens of a flavivirus, particularly of West Nile Virus (WNV) and methods for preventing, treating or ameliorating symptoms associated with a flavivirus, particularly of West Nile Virus (WNV) infection utilizing said ... 02/16/06 - 20060034853 - Novel human virus causing respiratory tract infection and uses thereof The present invention provides the complete genomic sequence of a novel human coronavirus, coined as human coronavirus-HKU1 (“HCoV-HKU1”), isolated in Hong Kong. The virus belongs to the order Nidovirales of the family Coronaviridae, being a single-stranded RNA virus of positive polarity. Futher study on nasopharyngeal aspirates from patients with community-acquired ... 12/22/05 - 20050281828 - Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells Antibodies to antigen presenting cells may be utilized to interfere with the interaction of the antigen presenting cell and immune cells, including T cells. Peptides may be linked to said antibodies thereby generating an immune response to such peptides. Preferably peptides linked to the antibodies are associated with autoimmunity. ... 11/10/05 - 20050249739 - Antibodies against sars-cov and methods of use thereof The invention provides scFv antibodies and monoclonal antibodies that neutralize SARS-CoV. Also provided are methods of treating and/or preventing a coronavirus-related disease or disorder such as SARS. The invention also provides methods of vaccinating a patient against SARS-CoV. Also provided are methods of diagnosing coronavirus-related diseases or disorders and methods ... 09/15/05 - 20050202024 - Protein sequences containing antigenized antibodies for foot-and-mouth disease Protein sequences encoding antigenized antibodies for treatment of foot-and-mouth disease (FMD) or foot-and-mouth disease virus (FMDV) of swine is provided. The antigenized antibodies are created from the grafting of peptide epitopes derived from FMDV into swine antibody CDR loops. FMDV peptide epitopes are cloned by PCR from VP1 gene of ... 07/21/05 - 20050158327 - Interrupting the interaction of intercellular adhesion molecule-1 and respiratory syncytial virus for prevention and treatment of infection There is provided a method of preventing a respiratory infection by administering an effective amount of an agent for regulating ICAM-1 expression. Also provided is a composition for the prevention of respiratory infection including an agent which regulates ICAM expression. Also provided is a method of preventing RSV infection by ... 07/21/05 - 20050158326 - Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof Disclosed is a composition for reducing virus infection rates in crustaceans, which can be applied in prevention and/or treatment of viral infection in crustaceans, and therefore improves the survival rate. The composition comprises at least one of the antibodies that can bind specifically to virus, and the antibodies are selected ... 07/14/05 - 20050152912 - Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen derived from a pathogen is disclosed. ... 07/14/05 - 20050152911 - Norovirus monoclonal antibodies and peptides The present invention is drawn to monoclonal antibodies that bind to a Norovirus, peptides that inhibit monoclonal antibody binding to a Norovirus, and peptides that inhibit binding of a Norovirus to a cell. The compositions of the invention find use as Norovirus immunogens, therapeutics, diagnostics, and vaccines. ... 07/14/05 - 20050152910 - Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same The invention relates to a novel variant of isolated and/or purified immunoglobulin IgG3 which can be used as a marker for protecting against infectious viral diseases such as AIDS, as a diagnostic tool, or as a preventive and curative medicament. The invention also relates to corresponding in vitro diagnostic methods. ... 07/07/05 - 20050147616 - Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of ... 06/16/05 - 20050129701 - Antibody to latent membrane proteins and uses thereof The present invention provides antibodies and antibody fragments directed against extracellular domains of the EBV LMP proteins, including LMP1, LMP2A and LMP2B. The invention also provides methods of treating EBV-associated malignancies using these LMP specific antibodies. ... 06/16/05 - 20050129700 - Compositions and methods modulating variola and vaccinia virus Antibodies directed to SPICE and VCP which may be used for detection, prevention, and treatment of variola virus or vaccinia virus are provided. Recombinant SPICE and VCP proteins are also provided which are used for enhancing the immune response to variola or vaccinia virus and modulating of complement activation. Methods ... ### FreshPatents.com Support |